{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:29:26Z","timestamp":1768318166679,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jbc.2024.108025","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T07:40:09Z","timestamp":1732693209000},"page":"108025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Thrombin confers chemotherapeutic resistance by promoting transcriptional induction and post-translational stabilization of pro-survival MCL1 in TNBC"],"prefix":"10.1016","volume":"301","author":[{"given":"Subhojit","family":"Paul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akash","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0386-0543","authenticated-orcid":false,"given":"Kaushik","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anushka","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhimanyu","family":"Basu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soma","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prosenjit","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2024.108025_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.jbc.2024.108025_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.jbc.2024.108025_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jbc.2024.108025_bib4","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2024.108025_bib5","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2024.108025_bib6","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1093\/annonc\/mdz189","article-title":"Erratum: early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jbc.2024.108025_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.breast.2021.03.002","article-title":"Clinical outcomes of platinum-based chemotherapy in patients with advanced breast cancer: an 11-year single institutional experience","volume":"57","author":"Franzoi","year":"2021","journal-title":"Breast"},{"key":"10.1016\/j.jbc.2024.108025_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-6253-5","article-title":"Triple negative breast cancer and platinum-based systemic treatment: a meta-analysis and systematic review","volume":"19","author":"Pandy","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jbc.2024.108025_bib9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.108025_bib10","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006080","article-title":"Cell death signaling","volume":"7","author":"Green","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jbc.2024.108025_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00241","article-title":"Exploitation of apoptotic regulation in cancer","volume":"9","author":"Ucker","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2024.108025_bib12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1476-4431.2008.00363.x","article-title":"Apoptosis: a review of pro-apoptotic and anti-apoptotic pathways and dysregulation in disease","volume":"18","author":"O\u2019Brien","year":"2008","journal-title":"J.\u00a0Vet. Emerg. Crit. Care"},{"key":"10.1016\/j.jbc.2024.108025_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.tibs.2013.12.006","article-title":"Many players in BCL-2 family affairs","volume":"39","author":"Moldoveanu","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jbc.2024.108025_bib14","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/emboj.2011.307","article-title":"Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases","volume":"30","author":"Strasser","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2024.108025_bib15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41418-019-0486-3","article-title":"Saga of Mcl-1: regulation from transcription to degradation","volume":"272","author":"Senichkin","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jbc.2024.108025_bib16","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3390\/cells3020418","article-title":"Mcl-1 ubiquitination: unique regulation of an essential survival protein","volume":"3","author":"Mojsa","year":"2014","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2024.108025_bib17","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0140-6736(97)10018-6","article-title":"Venous thromboembolism and cancer","volume":"351","author":"Baron","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jbc.2024.108025_bib18","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1016\/j.jtha.2023.08.008","article-title":"Coagulation factor VIIa enhances programmed death-ligand 1 expression and its stability in breast cancer cells to promote breast cancer immune evasion","volume":"21","author":"Paul","year":"2023","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.jbc.2024.108025_bib19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2006.10.002","article-title":"Thrombin induces tumor growth, metastasis, and angiogenesis: evidence for a thrombin-regulated dormant tumor phenotype","volume":"10","author":"Nierodzik","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2024.108025_bib20","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1158\/0008-5472.CAN-18-3206","article-title":"Thrombin signaling promotes pancreatic adenocarcinoma through PAR-1\u2013dependent immune evasion","volume":"79","author":"Yang","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2024.108025_bib21","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1182\/blood-2010-06-293126","article-title":"Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis","volume":"116","author":"McEachron","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2024.108025_bib22","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.96.20.11189","article-title":"Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity","volume":"96","author":"Andersen","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.108025_bib23","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41419-020-2725-4","article-title":"Twist-mediated PAR1 induction is required for breast cancer progression and metastasis by inhibiting Hippo pathway","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbc.2024.108025_bib24","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1182\/blood-2011-03-341222","article-title":"Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain","volume":"118","author":"Horowitz","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2024.108025_bib25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/nar\/28.1.302","article-title":"The eukaryotic promoter database (EPD)","volume":"28","author":"P\u00e9rier","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2024.108025_bib26","doi-asserted-by":"crossref","first-page":"13505","DOI":"10.1074\/jbc.R000025200","article-title":"CREB-Binding protein and p300 in transcriptional regulation","volume":"276","author":"Vo","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.108025_bib27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature14557","article-title":"The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1","volume":"524","author":"Han","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.108025_bib28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1042\/BJ20131115","article-title":"CREB phosphorylation at Ser133 regulates transcription via distinct mechanisms downstream of cAMP and MAPK signalling","volume":"458","author":"Naqvi","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2024.108025_bib29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-1-61779-316-5_17","article-title":"Sequential chromatin immunoprecipitation assay and analysis","volume":"791","author":"de Medeiros","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jbc.2024.108025_bib30","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.neuron.2019.11.028","article-title":"In\u00a0vivo imaging of the coupling between neuronal and CREB activity in the mouse brain","volume":"105","author":"Laviv","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.jbc.2024.108025_bib31","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.3390\/cells11132020","article-title":"cAMP signaling in cancer: a PKA-CREB and EPAC-centric approach","volume":"11","author":"Ahmed","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2024.108025_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cell.2004.09.015","volume":"119","author":"Screaton","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.108025_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrm3072","article-title":"CREB and the CRTC co-activators: sensors for hormonal and metabolic signals","volume":"12","author":"Altarejos","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2024.108025_bib34","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1073\/pnas.0914897107","article-title":"Targeted disruption of the CREB coactivator Crtc2 increases insulin sensitivity","volume":"107","author":"Wang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.108025_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101589","article-title":"Immunosuppressive calcineurin inhibitor cyclosporine A induces proapoptotic endoplasmic reticulum stress in renal tubular cells","volume":"298","author":"Yilmaz","year":"2022","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.108025_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.985363","article-title":"The role of BCL-2 family proteins in regulating apoptosis and cancer therapy","volume":"12","author":"Qian","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jbc.2024.108025_bib37","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.molcel.2006.02.009","article-title":"Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1","volume":"21","author":"Maurer","year":"2006","journal-title":"Mol. Cell."},{"key":"10.1016\/j.jbc.2024.108025_bib38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jbc.2024.108025_bib39","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-010-1293-1","article-title":"Triple negative breast cancer: unmet medical needs","volume":"125","author":"Pal","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jbc.2024.108025_bib40","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3390\/pharmaceutics15071796","article-title":"Triple negative breast cancer treatment options and limitations: future outlook","volume":"15","author":"Obidiro","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jbc.2024.108025_bib41","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/01.ATV.0000031340.68494.34","article-title":"Platelets and thrombin generation","volume":"22","author":"Monroe","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jbc.2024.108025_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.biopha.2003.11.007","article-title":"Antitumor and antimetastatic effect of warfarin and heparins","volume":"58","author":"Bobek","year":"2004","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jbc.2024.108025_bib43","doi-asserted-by":"crossref","first-page":"9409","DOI":"10.1128\/MCB.20.24.9409-9422.2000","article-title":"Magnitude of the CREB-dependent transcriptional response is determined by the strength of the interaction between the kinase-inducible domain of CREB and the KIX domain of CREB-binding protein","volume":"20","author":"Shaywitz","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jbc.2024.108025_bib44","doi-asserted-by":"crossref","first-page":"42241","DOI":"10.1074\/jbc.M207361200","article-title":"Roles of phosphorylation and helix propensity in the binding of the KIX domain of CREB-binding protein by constitutive (c-Myb) and inducible (CREB) activators","volume":"277","author":"Zor","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.108025_bib45","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jmb.2005.09.059","article-title":"Structural basis for cooperative transcription factor binding to the CBP coactivator","volume":"355","author":"De Guzman","year":"2006","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2024.108025_bib46","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0092-8674(00)82001-2","article-title":"The transcriptional coactivators p300 and CBP are histone acetyltransferases","volume":"87","author":"Ogryzko","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.108025_bib47","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.cell.2005.06.009","article-title":"Mule\/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis","volume":"121","author":"Zhong","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.108025_bib48","first-page":"1","article-title":"Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors","volume":"91","author":"Zhang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.108025_bib49","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature08646","article-title":"Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival","volume":"463","author":"Schwickart","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.108025_bib50","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1200\/JCO.2005.05.081","article-title":"The ubiquitin-proteasome pathway and its role in cancer","volume":"23","author":"Mani","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.jbc.2024.108025_bib51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/1574890110666150624100815","article-title":"Vorapaxar, a protease-activated receptor-1 antagonist, a double-edged sword","volume":"9","author":"Bhandari","year":"2014","journal-title":"Recent Adv. Cardiovasc. Drug Discov."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824025274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824025274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T21:14:12Z","timestamp":1738012452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925824025274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0021925824025274"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2024.108025","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombin confers chemotherapeutic resistance by promoting transcriptional induction and post-translational stabilization of pro-survival MCL1 in TNBC","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2024.108025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"108025"}}